United States · FDA National Drug Code directory

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
66993-596_88228827-17de-42dd-a08c-aacf516e0156
Product NDC
66993-596
Form
CAPSULE, EXTENDED RELEASE
Composition / generic term
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE
Labeler
Prasco Laboratories
Marketing category
NDA AUTHORIZED GENERIC
Marketing start / end (source format)
20090402 / 20270430

Source-listed ingredients

  • DEXTROAMPHETAMINE SACCHARATE — 3.75 mg/1
  • AMPHETAMINE ASPARTATE MONOHYDRATE — 3.75 mg/1
  • DEXTROAMPHETAMINE SULFATE — 3.75 mg/1
  • AMPHETAMINE SULFATE — 3.75 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66993-596-02) · 66993-596-02

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →